Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. About Delic Corp, Inc.

Research and Development 98

Research and Development Treatment Media Medicine 98

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 105

Consumption Patients Research and Development Data 105

Cannabis Law Report

DECEMBER 11, 2021

This reduction in prices will make the clinic the cheapest option for many patients looking to receive medical cannabis treatments for a wide variety of conditions and illnesses. Medical cannabis can be considered as a treatment for a number of conditions – including chronic pain, epilepsy, and insomnia – when first-line options have failed.

Access 52

Access Patients Chronic Pain Treatment 52

Veriheal

OCTOBER 29, 2020

On the brighter side, Science Magazine has indicated that the funding for cannabis as an effective form of treatment and therapy is rising, however not as much as the funding for its adverse impacts are. The data for this graphic was provided by Jim Hudson at Hellth.com. . It also shows that three countries (the U.S, Canada, and the U.K)

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

The Joint Blog

JULY 14, 2021

Osteoporosis. cardiovascular disease. anxiety. depression. arthritis chronic pain. seizures. hot flashes. insomnia. . However CBD oil is fast becoming an alternative treatment for senior citizens. CBD oil is good with supporting endocannabinoid systems and reduces pain as a result.

Medicine 52

Medicine CBD Chronic Pain Blood Pressure 52

Cannabis Law Report

NOVEMBER 16, 2021

Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. Recruitment for the Phase 2 trial will begin immediately, and efficacy data is expected by the end of first quarter of 2022. “To years of life with minimized chronic disease and maximized good health,” Dr. Chapman continued.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. Flora Pharma expects to fast track traditional FDA and NHS timelines by running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.).

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

The Joint Blog

APRIL 17, 2020

Crohn’s ), chronic pain , appetite loss , issues with sleep , immune system disorders , thermoregulation problems, cancer and more. While there have been significant studies done over the years, only chronic pain, antiemesis, multiple sclerosis , and sleep have any level of evidence of cannabis effectiveness.

Events 48

Events THC Chronic Pain Sleep 48

SpeedWeed

MARCH 6, 2021

Public safety at issue. Proponents of these THC caps—who are often the same politicians who stood against legalization and lost—contend that limiting THC levels will increase public safety. That 90-day limit works out to 50mg per day per patient, which is not much for patients managing chronic pain or other conditions. .

THC 52

THC Patients Law Chronic Pain 52

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

MARCH 19, 2020

2 At the conclusion of the meeting, FDA stated that it would form an internal working group to study data gaps relating to CBD. As indicated by FDA’s recent announcement, the collection of data about the risks and benefits of CBD remains a priority for the agency. FDA submitted this report last week, as is discussed below.

CBD 45

CBD Research and Development Seed-To-Sale Data 45

Cannabis Law Report

MAY 6, 2022

The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”. Taking CBD can relieve pain.”. “In

THC 52

THC CBD Media Food 52

Cannabis Law Report

JULY 24, 2019

Based on our review of your website, your “CBD Lotion,” “CBD Pain-Relief Patch,” “CBD Tincture,” and “CBD Disposable Vape Pen” products are drugs under section 201(g)(1) of the FD&C Act, 21 U.S.C. On your product webpage for CBD Tincture (Relieve): • “[S]oothing tincture for chronic pain.”. Chronic or arthritic pain.”.

CBD 51

CBD Tincture Pets Chronic Pain 51

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

The Joint Blog

DECEMBER 2, 2019

CBD could “significantly reduce opioid use and improve chronic pain and sleep quality among patients who are currently using opioids for pain management”, according to a new study. Data were collected at three different time points: baseline, 4, and 8 weeks.

Chronic Pain 68

Chronic Pain Sleep CBD Extraction 68

Cannabis Law Report

APRIL 12, 2019

I have successfully reduced 85% of my opioid use for chronic pain as the result of arthritis through several surgeries and medical cannabis. We aim to continue to do more for the Canadian patients who choose to use medical cannabis as a treatment option. Patient advocacy is alive and well in Canada.

Access 45

Access Patients Marijuana Medicine 45

Cannabis Law Report

DECEMBER 14, 2021

There are 28 million people suffering from chronic pain in the UK and this range of formulations offers pain doctors the best and most comprehensive selection of cannabinoid treatment options for their patients. to bring innovation and precision to the growing UK medical cannabis market.

Extraction 52

Extraction Patients Medicine Tincture 52

Cannabis Law Report

JULY 30, 2019

The ASA highlights that it takes the FDA “an average of 9 years to approve any drug, but it only takes approximately two to four weeks for a medical cannabis patient with chronic pain to be approved by a state program.” ” They have a dedicated “End Pain, Not Lives.”

Marijuana 40

Marijuana Education Patients Research and Development 40

Cannabis Law Report

OCTOBER 26, 2021

an organization that provides support to pharmaceutical and biotech companies in North America, Europe, Japan, India and Africa on issues such as product safety, pharmacovigilance, medical devices, clinical trials and regulatory issues. 1 Data published by Research and Markets, March 2018. About MYMD-1. MyMD: Robert Schatz.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Healer

APRIL 5, 2021

Among animal research, it’s clear that CBD can reduce pain and inflammation in various models of pain, including neuropathic pain, inflammatory pain, and arthritis-related pain.[1] After treatment with CBD oil (max dose 75 mg twice daily), participants achieved significant reductions in pain.[4].

CBD 98

CBD Chronic Pain Oil Topical 98

The Cannigma

JANUARY 13, 2023

The authors noted that while “promising data are emerging on the possible role of ECS in migraine…proper placebo-controlled trials are needed to establish a therapeutic role for cannabinoids.” 1 A 2008 study found serotonin and endocannabinoid levels, including anandamide, were lower in people with chronic migraines.

Terpenes 132

Terpenes Strains THC Treatment 132

Healer

APRIL 5, 2021

Among animal research, it’s clear that CBD can reduce pain and inflammation in various models of pain, including neuropathic pain, inflammatory pain, and arthritis-related pain.[1] After treatment with CBD oil (max dose 75 mg twice daily), participants achieved significant reductions in pain.[4].

CBD 52

CBD Chronic Pain Oil Topical 52

Healer

APRIL 5, 2021

Among animal research, it’s clear that CBD can reduce pain and inflammation in various models of pain, including neuropathic pain, inflammatory pain, and arthritis-related pain.[1] After treatment with CBD oil (max dose 75 mg twice daily), participants achieved significant reductions in pain.[4].

CBD 52

CBD Chronic Pain Oil Topical 52

The Cannigma

AUGUST 22, 2021

The researchers also stated that CBD microencapsulation in liposomes “showed a potential coating formulation for the development of an advanced biodegradable hygiene product for overcoming menstrual problems in daily use and as a curative treatment. The safety of CBD and other marijuana tampons may depend in part on where you live.

THC 119

THC CBD Research and Development Conditions 119

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

DECEMBER 8, 2021

Single-dose transdermal delivery of Epoladerm was well-tolerated in all minipigs and no treatment-related clinical observations, changes in body weight, or dermal irritation were observed. This data should strengthen the Company’s IND filing in advance of the anticipated start of first-in-human clinical trials.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Topical 52

Cannabis Law Report

MAY 13, 2019

“There’s still a lot we don’t know about medicinal cannabis … when it comes to the pharmacology, what does it do on a molecular level and how does it affect things like chronic pain or symptoms of MS [multiple sclerosis]?”. Data Availability: All relevant data are within the paper and its Supporting Information files.

Medicine 45

Medicine Research and Development Clinical Trials Data 45

Veriheal

SEPTEMBER 16, 2022

The company has taken up the responsibility to reduce pain and suffering of as many patients as they can, in the fastest way possible and they are “determined to make medical cannabis treatment a clinically standardized treatment utilizing advanced technology.”. Prevalence of Cannabis Use For Pain Management.

Patients 120

Patients Chronic Pain Research and Development Treatment 120

Cannabis Law Report

AUGUST 30, 2019

The US Department of Agriculture (USDA) has released new data indicating a substantial increase in the growth of US hemp production. Iowa’s Medical Cannabidiol Board formally approved a measure to add chronic pain to the list of conditions that qualify a patient for medical cannabis.

Banking 45

Banking Research and Development Legislation Programs 45

NORML

JANUARY 24, 2019

179 : The VA Medicinal Cannabis Research Act of 2019 to facilitate federally-sponsored clinical research into the safety and efficacy of medical cannabis among veterans. Representatives Lou Correa (D-CA) and Clay Higgins (R-LA) and Senators Jon Tester (D-MT) and Dan Sullivan (R-AK) have introduced legislation, HR 712 / S.

Legislation 223

Legislation Chronic Pain Safety Medicine 223

Healer

JUNE 28, 2019

‘Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.’ Patients with advanced cancer who have pain that responds poorly to opioid therapy pose a clinical challenge. Abstract: Medical Study . ’ Abstract. Portenoy, Russell K.,

Cannabinoids 52

Cannabinoids THC Therapy Patients 52

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. NL: I wish I had a healthcare provider help me. Honestly, it was trial and error.

Patients 83

Patients Compliance Compliance Cannabis 83

Cannabis Law Report

OCTOBER 17, 2019

Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. Another researcher, New Frontier Data, pegged the global value of legal and illicit cannabis together at $340 billion in 2018.

Law 40

Law Seed-To-Sale Hemp Recreational 40

NORML

JANUARY 28, 2019

It’s understandable lawmakers want reliable data before making a decision. The good news for Kentucky legislators is the data already i s available. We can all agree on objective scientific data. Danny Bentley, R-Russell, erroneously compared cannabis to “snake oil remedies of the 1800s,” according to a WDRB-TV report.

Data 186

Data Clinical Trials Chronic Pain Medicine 186

Cannabis Law Report

NOVEMBER 29, 2021

According to recent polling data , nearly seven in ten Americans, including majorities of all major subgroups by gender, age, income and education, and including majorities of Democrats, Independents, and Republicans, believe that the use of marijuana should be made legal. The law took effect on June 30, 2021. DRIVING/DUI.

Legislation 98

Legislation Patients Retail Access 98